4th Annual
Pulmonary Embolism Symposium:
What is Known, and What We Need to Know

June 22-23, 2018 / Nashville, TN

4th Annual Pulmonary Embolism (PE) Symposium

This annual two day AMA PRA/ANCC-accredited conference entitled, Pulmonary Embolism: What is Known, and What We Need to Know:  A State of the Art and Scientific Update’, is designed for practicing clinicians who regularly care for patients with pulmonary embolism (PE), as well as those who are interested in studying the pathophysiology, epidemiology, diagnosis, medical and interventional management, novel treatment paradigms, and outcomes of PE

Many would say that, when it comes to PE, we have an international crisis, given the prevalence of this disease, its enormous impact, and the relative lack of progress in its management. In fact, in 2008, the Surgeon General issued a “Call to Action” to improve the prevention, diagnosis and treatment of PE. Therefore, the purpose of this symposium is to improve the understanding of the pathophysiology, epidemiology, diagnosis, prevention and treatment of PE by educating our medical colleagues through a series of lectures and interactive discussions with thought leaders in the field.

Specifically, the goals of this Annual Scientific Symposium are:

  • To educate the medical community on the latest advances in the diagnosis, risk stratification and treatment of PE.
  • To explore the science behind PE diagnosis and treatment share knowledge regarding PE management.
  • To provide a forum for presentation of novel approaches to PE management, as they arise.
  • To recognize the potential complications from PE and how to prevent and treat them.
  • To highlight unique patient populations and their specific treatment challenges.
  • To promote and enhance coordinated, multidisciplinary care of PE patients.
  • To explore opportunities for quality improvement in PE management

 

Registration

Please click the link above to register for the meeting. In order to register, you will first have to create an account with the Boston University CME office and then proceed to sign up for the event.

Required Fees

MD/DO Early Bird Registration
($395 after June 1, 2018)
$250.00
Professional from Founding/Institutional Member
or Provisional PERT Consortium Member

(Must be validated by Staff)
$150.00
Nurse/NP/PA $150.00
Fellow/Trainee $99.00
Industry Professionals $500.00

 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and PERT Consortium. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.Boston University School of Medicine designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This educational activity is being provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly-provided by PERT Consortium.

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

 

Program Overview

Day 1: Friday, June 22
6:30-7:50 AM
Registration / Continental Breakfast
7:50–8:00
Welcome and Opening Remarks
—Kenneth Rosenfield, MD
8:00–8:55
SESSION I
PE EPIDEMIOLOGY & GLOBAL IMPACT, CLINICAL PRESENTATION & PREDICTIVE MODELING

—Moderators: Victor Tapson, Geoffrey Barnes and Jerry Bartholomew
-
Bending the PE Curve: Raising Awareness and Reducing the Global Impact of the PE Epidemic
—Victor Tapson, MD
Pre-test Probability: How well can we predict the presence of PE… what do the data show?
—David Jimenez, MD
Increasing sensitivity and specificity in detection of PE: Use of the PERC Rule and other tools?
—Jeffrey Kline, MD
Look at the patient, not just the studies!
- Key clues on physical exam suggesting the diagnosis of PE
-”Fool me once, but don’t fool me twice”—The many faces of PE (Case-based presentation with Audience polling)
—Christopher Kabrel, MD
Interactive Panel Discussion - Q & A with the Experts
8:55–9:40
SESSION II
DIAGNOSTIC EVALUATION: ADVANCES IN IMAGING, LAB, AND CLINICAL ASSESSMENT

—Moderators: Soophia Naydenov, Seth Sokol and Rich Channick
CT for diagnosis and risk-stratification in PE - What’s the Latest?
—Ethan Halpern, MD
More POCUS, Less HOKUS...Role of Point Of Care UltraSound for Diagnosis
Case Challenges ...I thought I had it right!
(Echos, CTA’s, with Unexpected Findings)
Audience Polling
—Ido Weinberg, MD; Soophia Naydenov, MD; Seth Sokol, MD; Amit Kakkar, MD
Interactive Panel Discussion - Q & A with the Experts
9:40–10:00
Break / Visit Exhibits
10:00–11:30
SESSION III
DEFINING PE SEVERITY TO TRIAGE CARE... GUIDELINES, MANAGEMENT DECISIONS AND PERTS

—Moderators: Victor Tapson, Jana Montgomery, Michael McDaniels and Akhilesh Sista
European Guidelines - Best evidence-based approach available?
—Menno Huisman, MD
Biomarkers and Clinical Risk Scores: How accurate/effective are they to stratify risk?
—David Jimenez, MD
Hypoxemia in Acute Pulmonary Embolism—Pathophysiology and Influence on Management
—Steven Pugliese, MD
The “IDEAL” Guidelines—What data are still required to create these?
—James Douketis, MD
Value of team-based care. Team-based care increases institutional awareness and enhances care for PE patients
—Jana Montgomery, MD
Challenges and Obsticals of a PERT and How to Overcome Them
—Rachel Rosovsky, MD
International Perspectives on Care of PE —Roundtable Discussion
Moderator: Victor Tapson
Panelist: Menno Huisman, David Jimenez, James Douketis, Andrew Hirsch, Nie Shaoping, Gregory Piazza
11:30–11:50
Patient Perspective with Pat Bayliss - Interview and Audience Q&A
—Moderators: Ken Rosenfield, Victor Tapson and Brent Keeling
11:50–1:15
Lunch and Sponsored Satellite Sessions
Sponsored Satellite
Lower Dose, Shorter Duration Therapy: OPTALYSE PE Trial – Acute and 1-Year Results
—Gregory Piazza, MD, MS
Sponsored by: EKOS Corporation, a BTG International group company
An Evidence-Based Approach to Reducing Risk of Recurrent Venous Thromboembolism
— Jason Wilson, MD
Sponsored by: Janssen Pharmaceuticals, Inc.
1:15–2:25
SESSION IV
ANTICOAGULATION UPDATE: CONTROVERSY AND PROGRESS

—Moderators: Roy Smith, George Davis and Rachel Rosovsky
Case Presentation with audience polling
—Roy Smith, MD
The GREAT PERT Debate II: Anticoagulation Alone Versus Lysis
Pro: Intermediate High-risk Submassive PE is best treated with anticoagulation alone! —Scott Kaatz, MD
Con: Intermediate High-risk Submassive PE is best treated with systemic or catheter-directed thrombolysis! —Gregory Piazza, MD
2018 Update on Direct Oral Anticoagulants (DOACs) for VTE treatment: Role as primary therapy for PE and transition after lysis...the Anticoagulation Revolution Continues
—Adam Cuker, MD
VTE Prophylaxis—Cost and Risk: From Exclaim to Apex...and now Mariner
—Geno Merli, MD
New Approaches to Prevention in Hospitalized Patients: Use of an Individualized Risk Score for VTE
—Robert Eberhardt, MD
Interactive Panel Discussion - Q & A with the Experts
2:25–2:30
Transition to Breakout Sessions
2:30–3:30
SESSION V
CONCURRENT BREAKOUT SESSIONS 1-4
Breakout Session I
“After the PE”: Long Term Surveillance and Post-PE Syndromes (CTED and CTEPH)
—Moderators: Andrew Hirsch, Rich Channick and William Auger
Post-PE syndrome: What is it, how often does it occur
—Andrew Hirsch, MD
Follow-up after PE:  What I do.  What do you do?
—Tim Morris, MD
Transition from acute to chronic thromboembolic disease: What we know (and don’t know) about pathogenesis of CTEPH
—William Auger, MD
CTED and CTEPH:  What are they? What do we do about them?
—Rich Channick, MD
Panel Discussion - Q & A with the Experts
Breakout Session II
Quality Assurance In PE Treatment: Benchmarking Outcomes with a QA Program
—Moderators: George Davis, Alain Drooz and Jay Giri
What are Quality Assurance Benchmarks in 2018? —Robert Lookstein, MD

Pro: We ARE ready for national Quality Assurance Benchmark metrics for Pulmonary Embolism —Geoffery Barnes, MD
Con: We ARE NOT ready for national Quality Assurance Benchmark metrics for Pulmonary Embolism —Ido Weinberg, MD
Panel Discussion - Q & A with the Experts
FDA perspective on Data Quality Assurance regarding the PERT registry.
—Jose Pablo Morales, MD
Breakout Session III
Practical Guide to Anticoagulation: What agents, how long, and in which patients… What you need to know!
Moderators: Rachel Rosovsky, Jerry Bartholomew and John Fanikos
Topic 1: What agent to use for what patient (daily vs bid, GI issues, RH strain).
Title: Five DOACS and more Coming. Which one do I choose?
—Rachel Rosovsky, MD
Topic 2: Peri-procedural management of anticoagulation 
—Scott Kaatz, MD
Topic 3: Management of bleeding while on AC. How do I get the Bleeding to Stop?
—Jerry Bartholomew, MD
Topic 4: Timing is Everything. Optimum duration of anticoagulation in VTE
—Menno Huisman, MD
Topic 5: How often and what, different if elderly or not. Title: Measurement or Monitoring? The best Lab test for DOACs
—Adam Cuker, MD
Topic 6: DOAC Therapy and the Unexpected-What do I do next?
—Gregory Piazza, MD
Breakout Session IV
What was I thinking?
Complications and missed opportunities in management of PE and VTE cases
—Moderators: Robert Lookstein and David Slosky
3:30–3:45
Break / Visit Exhibits
3:45–4:45
SESSION VI
INTERVENTIONAL BATTLE ROYALE:
SPARRING WITH THE EXPERTS ON CHOICE OF ADVANCED CATHETER-BASED THERAPY

—Moderators: W. Brent Keeling, Thomas Todoran and Akhilesh Sista
Catheter Directed Lysis —Jay Giri, MD
“Hot off the Press”
Optylase Influence on Clinical use of Ultrasound Facilitated Lysis
—Victor Tapson, MD
Small Catheter Aspiration —Akhilesh Sista, MD
Large Catheter Aspiration —Wissam Jaber, MD
Thrombectomy with Veno-Veno Bypass —John Moriarty, MD
Rheolytic Thrombectomy —Rohit Bhatheja, MD
Clot in Transit: Sword of Damocles —Thomas Todoran, MD
Interactive Panel Discussion - Q & A with the Experts
5:00–5:30
SCIENTIFIC ABSTRACT COMPETITION WITH MODERATED POSTER PRESENTATONS
Moderators: Rachel P. Rosovsky, Aaron Weinberg, Alison Witkin and Belinda-Rivera-lebron
5:30–7:00
Reception with Sponsors
Day 2: Saturday, June 23
7:00-8:00 AM
Sponsored Satellite Sessions
PERT Sponsored Session
How to Create a PERT and Optimize its Function
PERT Sponsored Session
PERT Working Group on Balloon Pulmonary Angioplasty (BPA) for CTEPH
PERT Sponsored Session
BREAKFAST OF CHAMPIONS: Meet the International PE Experts
PERT Sponsored Session
PERT FELLOWS SESSION: PERT Trainee Satellite Symposium
6:30–7:55
Registration / Continental Breakfast
7:55–8:00
Welcome and Opening Remarks
—W. Brent Keeling, MD
8:00-9:10
SESSION VII
SYMPOSIUM ON MASSIVE PE - SURGERY, CARDIOPULMONARY SUPPORT, AND CRITICAL CARE

—Moderators: Andrew Klein and W. Brent Keeling
Panel Discussion: Defining What is Truly Massive PE…New definitions required!
—Andrew Klein, MD and W. Brent Keeling, MD
IV Thrombolysis - Is it treatment of choice for Massive PE?
—Mike McDaniel, MD
Surgery for Massive PE - Should it happen more?
—Lyle Joyce, MD
CDT for Massive PE...why not?
—Thomas Todoran, MD
When to call the ECMO team for Cardiopulmonary support and how to use ECMO as a “bridge” to definitive therapy
—John Gurley, MD
Right Ventricular Support - Indications and Options
—Mahir Elder, MD
Cardiac Arrest and Unstable PE in the Critical Care Unit - Clinical Pearls
—Oren Friedman, MD
“Hot off the Press”
Role of Inhaled Nitric Oxide in PE…The iNOPE Trial
—Jeffrey Kline, MD
Interactive Panel Discussion - Q & A with the Experts
9:10–10:25
SESSION VIII
BEST PRACTICE FOR PE MANAGEMENT: CONTROVERSIES AND CONUNDRUMS

—Moderators: Jerry Bartholomew, Jim Benenati and Raghu Kolluri
“Transfer PE”—Best Practices for Stabilization and Transfer of Patients with Large PE in Community-based Setting
—Chad Miller, MD
The Great PERT Debate III: All high-risk PE’s should be transferred to a PE Center of Excellence with the full range of therapies available
Pro: All high risk PE’s should be transferred to a PE Center of Excellence with the full range of therapies available —Charles Ross, MD
Con: Most high risk PE can be treated in community Centers of excellence won’t alter outcomes —Lee Greenspon, MD
The Great PERT Debate IV: Use of IVC Filters in management of the PE and VTE
Pro: IVC Filters can be lifesaving and should be used more routinely in PE patients —James Benenati, MD
Con: IVC Filters are not indicated and should almost never be implanted —Raghu Kolluri, MD
Indications to leave the filter in, and how to make sure the others come out
—Ido Weinberg, MD
What is the Definition of “Good PE Care”? Establishing Metrics and Benchmarks for Excellence
—David Dudzinski, MD
PE Quality Mandate: What is the Role of the PERT QA and Research Registry (PQRR)
—Susan Smythe, MD
Interactive Panel Discussion - Q & A with the Experts
10:25–10:55
Break / Visit Exhibits
10:55–12:10
WORKSHOPS — BLOCK I
“DEEP DIVE” PEER-TO-PEER SESSIONS & HANDS-ON WORKSHOPS
Workshop I
DVT and IVC Filter — Hands-on device workshop
— Robert Schainfeld, Raghu Kolluri, Mahmood Razavi
Workshop II
Challenging Patient Subsets - Part 1:
PE in Pregnancy, Cancer Patients, Hemophila Patients, and More
—Rachel Rosovsky, Susan Smyth, Soophia Naydenov, Jeffrey Kline, Mae Wes, James Doketis and Menno Huisman
PE and Cancer —Menno Huisman, MD
PE in Pregnancy —Frances Mae West, MD
PE and Hypercoagulable States —James Douketis, MD
PE in Patients with End of Life Conditions —Jeffrey Kline, MD
PE and Antiphospholipid Syndrome —Rachel Rosovsky, MD
PE and Recurrent VTE —Jerry Bartholomew, MD
Workshop III
Latest In CTEPH Management - Surgery and BPA
—Richard Channick, Tim Morris, Kenneth Rosenfeild, William Auger, Ivan Robbins
Surgery Latest and Greatest —Willim Auger, MD
Quick Overview of BPA, Case Example and Maybe Show Our Data — Allison Witkin, MD
Workshop IV
Invasive Management & Hemodynamic Support in Massive Pe
—Hands on device workshop
—Moderator: Sahil A. Parikh, MD
RV Hemodynamics and Shock in PE —Sahil A. Parikh, MD
Supporting the Right Heart: Medical Therapy —Aaron Weinberg, MD
Supporting the Right Heart: Protek Duo —Christopher Barnett, MD
Supporting the Right Heart: Impella RP —Mahir Elder, MD
Supporting the Right Heart: ECMO —Ramin Malekan, MD
Hands on —All Faculty Working with Attendees
1) Tandemlife, ECMO and DUO
2) BTG Cardiohelp
3) AbioMed Impella
Panel Discussion - Q & A with the Moderators
12:10–1:30
Lunch and Sponsored Satellite Sessions
Sponsored Satellite
New Standard for Extended VTE Thromboprophylaxis in Hospitalized, Nonsurgical, Acutely Ill Patients
— Robert Takla, MD
Sponsored by: Portola Pharmaceuticals
Challenges of Treating Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in the Hospital Setting
—Ronald Goldenberg, MD
Sponsored by: Pfizer Inc.
1:30–1:50
The Most Complicated PE Case You Can Imagine
Case Presentation & Discussion with Experts
1:50–3:15
SESSION IX
THE PE RESEARCH MANDATE: FILLING THE EVIDENCE GAP
Most important current and future research in PE — Geoffrey Barnes, MD
The INVENT Clinical Trials Network: Will this provide us the answers we seek?
— Geoffrey Barnes, MD
FDA’s role and Perspective on filling the evidence gap —Jose Pablo Morales, MD
Interactive Panel Discussion - Q & A with the Experts
-
MOST INTERESTING PE PAPERS OF THE YEAR - Panel Discussion
—Moderators: Christopher Kabrhel and Geno Merli
3:15–3:20
Course Directors Wrap-up
3:20–3:30
Break
3:30–4:45
WORKSHOPS — BLOCK II
“DEEP DIVE” PEER-TO-PEER SESSIONS & HANDS-ON WORKSHOPS
Workshop V
Social Media, PERT Apps, and more: Tools to inform patients and help me manage PE
—Andrew Klein, Ido Weinberg,
PERT and Social Media: Why….who has the time anyways?
—Ido Weinberg, MD and Allison Witkin, MD
How not to use SoMe” aka “SoMe safety (for you and the patient)”
—Aaron Weinberg, MD
APPs for PERT: Are there any and what should an IDEAL PERT look like?
—Andrew Klein, MD
PERT and Other SoMe Venues: LinkedIn, Facebook, how do and how should we use these
The web is not dead —Matthew Langston, MD
Wrap up: SoMe and APPs, APPs - when to use them and how?
—Andrew Klein, MD, Ido Weinberg, MD
Workshop VI
Outpatient Management Of Low Risk PE:
Algorithms for successful treatment and prevention of recurrence
—Moderators: Mark Courtney,MD; Aditya Sharma, MD and Belinda Rivera-Lebron, MD
When do I not admit my PE patient to the hospital?
—Mark Courtney, MD
Anticoagulant selection in Low Risk PE: DOACS (which DOAC) vs. Warfarin vs. LMWH
—John Fanikos, MD
Anticoagulation duration in Low Risk PE —Gregory Piazza, MD
When and why do I order thrombophilia testing? A Case-Based scenario
—Roy E. Smith, MD
When do I anticoagulate subsegmental PE?
—Belinda Rivera-Lebron, MD
When do I obtain a lower extremity venous Doppler on acute PE?
—Raghu Kolluri, MD
Implications on Healthcare system by developing Early Discharge PE programs and Outpatient Follow-up Protocols to safely manage these patients
—Aditya Sharma, MD
Workshop VII
Advanced Thrombectomy Hands-On Device Workshop:
How to use these devices most effectively and safely
—Moderators: Charles Ross, MD; James Benenati,MD and Akhi Sista, MD
Introduction and Device Overview  —James Benenati, MD
Matching Case and Best Device —Wissam Jaber, MD
Back-up rescue techniques when your first device isn’t getting the job done
—Thomas Tu, MD
Hands-On Lab Stations
Wrap-Up —Akhilesh Sista, MD
Workshop IV
Challenging Patient Subsets- Part 2:
Case-based approach for patients at high risk for bleeding - Neuro, Post-op, Trauma, and Thrombocytopenic Patients
—Moderators: Jana Montgomery, MD; Gerald Koenig, MD; Seth Sokol, MD and David Dudzinski, MD
High Bleeding Risk Patient Populations and Treatment Options —Seth Sokol, MD; Gerald Koenig, MD
Thrombolytics , Anticoagulation, Antithrombotic Options for Treatment of the Thrombocytopenic Patient
—Michael McDaniel, MD and, Roy E. Smith, MD
Mechanical Thrombectomy Treatment and Level of Evidence
Post-Op Case —Amit Kakkar, MD
Trauma Case —Aksim Rivera, MD
DMD Case —James Benenati, MD
Role of IVC Filters
—Amit Kakkar, MD and John Kaufman, MD or Michael Jaff, DO
4:45
Adjourn

Faculty

W. Brent Keeling, MD
COURSE DIRECTOR
Geno J. Merli, MD
COURSE DIRECTOR
Kenneth Rosenfield, MD, MHCDS
COURSE DIRECTOR
Victor Tapson, MD, FCCP, FRCP
COURSE DIRECTOR

Invited Faculty

ASSOCIATE COURSE DIRECTORS

William R. Auger, MD
UC San Diego School of Medicine
San Diego, CaliforniaGeoff Barnes, MD, MSc
University of Michigan Health
System
Ann Arbor, MIJerry Bartholomew, MD
Cleveland Clinic
Cleveland, OhioJames F. Benenati, MD
Miami Baptist Hospital
Miami, FLRichard N. Channick, MD
Mass General Hospital for Children
Boston, MAGeorge Davis, PharmD
University of Kentucky College
of Pharmacy
Lexington, KY
Oren Friedman, MD
Cedars-Sinai Medical Center
Los Angeles, CAJay Giri, MD
Hospital of the University
of Pennsylvania
Philadelphia, PASam Goldhaber, MD
Brigham and Women’s Hospital
Boston, MAGustavo A. Heresi, MD
Cleveland Clinic
Cleveland, OHJames Horowitz, MD
NYU Langone School of Medicine
New York, NYMichael Jaff, DO
Newton Wellesley Hospital
Newton, MA
Christopher Kabrhel, MD
Massachusetts General Hospital
Boston, MAAndrew J. P. Klein, MD
Piedmont Heart Institute
Atlanta, GARobert Lookstein, MD
The Mount Sinai Hospital
New York, NYRobert Maholic, DO
University of Pittsburgh
Medical Center
Pittsburgh, PAJana Montgomery, MD
Lahey Hospital & Medical Center
Burlington, MASoophia Naydenov, MD, FCCP
SSM Health Saint Louis
University Hospital
St. Louis, MO
Charles B. Ross, MD
Piedmont Heart Institute
Atlanta, GAAkhilesh K. Sista, MD
NYU Langone School of Medicine
New York, NYDavid A. Slosky, MD
Vanderbilt Heart
Nashville, TNRoy E. Smith, MD
University of Pittsburgh Medical
Center
Pittsburgh, PASeth Sokol, MD
Jacobi Medical Center
Bronx, NYThomas M. Todoran, MD, MSc
Medical University of South
Carolina
Charleston, SC

 

 

SCIENTIFIC ABSTRACT & ASSOCIATE COURSE DIRECTORS

Belinda N. Rivera-Lebron, MD
University of Pittsburgh Medical
Center
Pittsburgh, PA
Rachel Rosovsky, MD
Massachusetts General Hospital
Boston, MA
Aaron Weinberg, MD
Cedars Sinai Medical Center
Los Angeles, CA
Alison S. Witkin, MD
Massachusetts General Hospital
Boston, MA

 

 

INVITED FACULTY

Riyaz Bashir, MD
Temple University
Philadelphia, PAJoshua Beckman, MD
Vanderbilt University
Medical Center
Nashville, TNRohit Bhatheja, MD
Florida Hospital
Orlando, FLABrett Carrol, MD
Brigham and Women’s Hospital
Boston, MAJoanna Chikwe, MD
Mount Sinai
New York, NYMark Courtney, MD
Northwestern University
— Feinberg School of Medicine
Chicago, ILAdam C. Cuker, MD
University of Pittsburgh
Medical Center
Pittsburgh, PAJames Douketis, MD
McMaster University
Hamilton, ON, CanadaAlain Drooz, MD
Inova
Fairfax, VA

David Dudzinski, MD
Massachusetts General Hospital
Boston, MA

Robert T. Eberhardt, MD
Boston Medical Center
Boston, MA

Mahir D. Elder, MD
Detroit Medical Center
Detroit, MI

John Fanikos, MBA, RPh
Brigham and Women’s Hospital
Boston, MA

Caio Fernandes, MD
University of Sao Paulo
Sao Paulo, Brazil

C. Michael Gibson, MS, MD
Baim Institute for Clinical Research
Boston, MA

John Gurley, MD
University of Kentucky College
of Medicine
Lexington, KYEthan Halpern, MD
Jefferson University Hospital
Philadelphia, PAJohn A. Heit, MD
Mayo Clinic
Rochester, MNAndrew Hirsch, MD
Jewish General Hospital
Montréal, Qué., CanadaMenno Huisman, MD, PhD
Leiden University Medical Center
Leiden, NetherlandsWissam Jaber, MD
Emory School Of Medicine
Atlanta, GADavid Jiménez, MD
Ramon y Cajal Hospital IRYCIS
Alcala de Henares University
Madrid, SpainDavid Joyce, MD
Froedtert Hospital
Milwaukee, WIScott Kaatz, DO
Henry Ford Hospital
Detroit, MI

John A. Kaufman, MD
Oregon Health
& Science University
Portland, OR

Clive Kearon, MB, MRCPI
McMaster University
Hamilton, ON, Canada

Nick H. Kim, MD
UC San Diego
La Jolla, CA

Jeffrey A. Kline, MD
Indiana University Medical Center
Indianapolis, IN

Raghu Kolluri, MD
OhioHealth Heart & Vascular
Columbus, OH

Irene Lang, MD
Medical University of Vienna
Wien, Austria

Matthew D. Langston, MD
Albert Einstein College
of Medicine
Bronx, NY

Omar Lattouf, MD
Emory University School
of Medicine
Atlanta, GAEhtisham Mahmud, MD
University of California
San Diego
San Diego, CAMark Marinescu, MD
Ohio State University
Columbus, OHSagger Mawri, MD
Henry Ford Hospital
Detroit, MIMichael McDaniel, MD
Grady Memorial Hospital
Atlanta, GAGuy Meyer, MD
Paris Descartes University
Paris, FranceChad E. Miller, MD
Piedmont Healthcare
Atlanta, GAManuel Monreal, MD
Hospital Universitari
Germans Trias i Pujo
Barcelona, SpainJose Pablo Morales, MD
U.S. Food and
Drug Administration
Washington, DC

John Moriarty, MD
UCLA Medical Center
Los Angeles, CA

Jeffrey W. Olin, DO
The Mount Sinai Hospital
New York, NY

Sahil A. Parikh, MD
NewYork-Presbyterian Hospital
New York, NY

Blair Parry, MD
Massachusetts General Hospital
Boston, MA

Gregory Piazza, MD
Brigham and Women’s Hospital
Boston, MA

Steven Pugliese, MD
Perelman Center for
Advanced Medicine
Philadelphia, PA

Parth Rali, MD
Temple University Hospital
Philadelphia, PA

Mahmood Razavi, MD
St. Joseph Hospital
Orange, CABelinda N. Rivera-Lebron, MD
University of Pittsburgh
Medical Center
Pittsburgh, PARachel Rosovsky, MD
Massachusetts General Hospital
Boston, MARobert M. Schainfeld, DO
Massachusetts General Hospital
Boston, MAAshish Shah, MD
Andover Medical Center
Andover, MASusan Smyth, MD
University of Kentucky
College of Medicine
Lexington, KYKeith Sterling, MD
Inova Alexandria Hospital
Alexandria, VAMichael Streif, MD
The Johns Hopkins Hospital
Baltimore, MDAaron Weinberg, MD
Cedars Sinai Medical Center
Los Angeles, CA

Ido Weinberg, MD
Massachusetts General Hospital
Boston, MA

Jeff Weitz, MD
McMaster University
Hamilton, ON, Canada

Philip Wells, MD, MSc
University of Ottawa
Ottawa, ON, Canada

Frances Mae West, MD
Thomas Jefferson University
Philadelphia, PA

Alison S. Witkin, MD
Massachusetts General Hospital
Boston, MA

Todd Wood, MD
The Heart Group of
Lancaster General Health
Lancaster, PA

Hotel Booking & Visiting Nashville

Sheraton Grand Nashville Downtown
623 Union St
Nashville, TN 37219

To secure accommodations and receive the negotiated special guest rate at the official conference hotel, please reserve by June 4, 2018. To make your reservations, you can book online using the following hotel website link:
https://www.starwoodmeeting.com/Book/PERTConsortium

Or, if you prefer, you can also contact Sheraton Grand Nashville Downtown reservations at 1-888-627-8565 or the hotel directly at 615-259-2000.

 


 

Nashville Skyline NightNashville is the capital of the U.S. state of Tennessee and home to Vanderbilt University. Legendary country music venues include the Grand Ole Opry House, home of the famous “Grand Ole Opry” stage and radio show. The Country Music Hall of Fame and Museum and historic Ryman Auditorium are Downtown, as is the District, featuring honky-tonks with live music and the Johnny Cash Museum, celebrating the singer’s life.

Visit www.visitmusiccity.com/ for more information on things to do and see while in Nashville